A GP in the Midlands sends an urgent referral for a patient with unexplained weight loss and a palpable abdominal mass. Days later it returns, not as an appointment, but as a request for more information: could primary care arrange further blood tests first. The patient, unaware anything has changed, continues waiting. Nothing on paper has gone wrong. The referral has simply been converted, quietly, into something else.

This is the mechanism GPs increasingly describe when they talk about Advice and Guidance, the digital triage system NHS England has built into the architecture of primary to secondary care communication. A&G was created as a bridge for genuinely ambiguous situations, enabling a GP to consult with a specialist before to referring a patient to a potentially unnecessary medical route.  NHS England's own Medium Term Planning Framework, published last October, is explicit that suspected cancer referrals sit outside this model. The 2026/27 GP contract changes go further, folding A&G's enhanced service funding into core practice payments and asking practices to route referrals through it wherever clinically appropriate, while repeating the same carve-out for urgent cancer cases.

The written safeguard is clear. What GPs describe happening at the point of care is less so. Survey data gathered from general practice has consistently found doctors reporting that referrals, including urgent ones, are being redirected or rejected for reasons that look more like capacity management than clinical assessment. A Healthwatch poll published in December found that one in seven patients referred by their GP for specialist care ends up stuck between primary and secondary teams, their referral delayed, lost or bounced back. Three quarters of that group reported some harm to their health or wellbeing as a result. Most only discovered the problem by chasing it themselves.

The exclusion for cancer referrals was written to prevent exactly this kind of drift. Whether it is holding depends less on the wording of national guidance than on what happens inside individual trusts under sustained diagnostic and workforce pressure, where a specialist reviewing a queue of digital requests has every operational incentive to ask for one more test before accepting a case onto a formal pathway. Each such decision may be defensible in isolation. Repeated across a system already straining under backlog, it produces a slow erosion of the very protection the policy claims to guarantee.

Two consequences follow, and both matter to anyone responsible for running or overseeing the system. The first is medico-legal. When a referral is converted into an advice request rather than accepted, clinical responsibility for the patient reverts to the GP, who typically lacks the diagnostics or specialist access to resolve the underlying concern. That transfer happens with none of the accountability structures that would apply to a formal handover. The second is statistical. Referrals that are rerouted to A&G are not included in the two-week wait monitoring that controls cancer pathways. As a result, the very data that NHS England uses to determine whether its goals are being reached may be underestimating the number of patients who are actually waiting.

This does not mean A&G is a failed idea. Used as intended, it has genuine value in reducing unnecessary hospital attendances and freeing specialist time for the patients who need it most. The difficulty is that NHS England is now expanding its role and its funding within the GP contract at precisely the moment frontline evidence suggests its boundaries are not being respected in practice. A reform can be sound in design and still fail in delivery, and the gap between the two is where patients with red flag symptoms currently sit.

What NHS leaders and ministers do next will say something about how seriously the government takes its own safeguards. Without first creating trustworthy monitoring of how trusts are actually utilising it, incorporating A&G more thoroughly into the contract runs the risk of legitimising the very gap that the policy was designed to stop. The referral that comes back marked "further information required" may look, on a dashboard, like sensible triage. For the patient behind it, it can look like something closer to being quietly turned away.